CHARLESTON, SC—The SCBIO 2018 Annual Conference was a major success, with pharmaceutical and biotech industry leaders and government officials and educators gathering in Charleston for the three-day life sciences conference.

Registrants include top officials across a broad spectrum of life sciences industries including:

  • Medical devices and medtech;
  • Biomanufacturing;
  • Drug discovery/R&D;
  • Pharmaceutical;
  • Diagnostics and testing;
  • Digital health and Health IT;
  • Bioscience-related distribution; and
  • BioAg.

Womble Bond Dickinson played a significant role in SCBIO 2018. Womble Bond Dickinson attorney Stephanie Yarbrough served as Chair of this year’s conference and also moderated a panel discussion on “Advancing Life Sciences Economic Development”.

In addition, attorney Alexandra Villarreal O’Rourke moderated a panel discussion on “Data & IT: The New Currency of Healthcare”. Laramie Paras headed the SCBIO Volunteer Committee, while Keith Munson provided welcoming remarks at the Womble Bond Dickinson-sponsored after-hours reception.

Other Womble Bond Dickinson attendees included attorneys Chuck Baker, Christopher Bolen, Logan Buck, David Crawford, Brandy Davis, Kevin Trempe, Alissa Fleming, Allen Gibson and Henry Smythe and Regulatory Scientist Heather Hatcher.

Marketing & Client Resources Manager Lisa Lindquist worked closely with Yarbrough on planning and coordinating the conference, which took place Oct. 23-25.

Click here to read more about Womble Bond Dickinson’s participation in SCBIO 2018.